Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease
- 1 August 1997
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 231 (3) , 175-178
- https://doi.org/10.1016/s0304-3940(97)00558-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Brain Expression of Apolipoproteins E, J, and A‐I in Alzheimer's DiseaseJournal of Neurochemistry, 1996
- Expression of the Very Low-Density Lipoprotein Receptor (VLDL-r), an Apolipoprotein-E Receptor, in the Central Nervous System and in Alzheimerʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1996
- Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's diseaseAnnals of Neurology, 1995
- Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's diseaseHuman Genetics, 1995
- Cerebrospinal fluid apolipoprotein E is reduced in Alzheimerʼs diseaseNeuroReport, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytesJournal of Virology, 1991
- A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal TauScience, 1991
- A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.Journal of Clinical Investigation, 1989
- A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populationsClinical Genetics, 1986